Correlation Between Live Ventures and Centessa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Live Ventures and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Live Ventures and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Live Ventures and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Live Ventures and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Live Ventures with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Live Ventures and Centessa Pharmaceuticals.
Diversification Opportunities for Live Ventures and Centessa Pharmaceuticals
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Live and Centessa is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Live Ventures and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Live Ventures is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Live Ventures are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Live Ventures i.e., Live Ventures and Centessa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Live Ventures and Centessa Pharmaceuticals
Given the investment horizon of 90 days Live Ventures is expected to under-perform the Centessa Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Live Ventures is 1.05 times less risky than Centessa Pharmaceuticals. The stock trades about -0.19 of its potential returns per unit of risk. The Centessa Pharmaceuticals PLC is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 1,691 in Centessa Pharmaceuticals PLC on December 1, 2024 and sell it today you would lose (136.00) from holding Centessa Pharmaceuticals PLC or give up 8.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Live Ventures vs. Centessa Pharmaceuticals PLC
Performance |
| Timeline |
| Live Ventures |
| Centessa Pharmaceuticals |
Live Ventures and Centessa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Live Ventures and Centessa Pharmaceuticals
The main advantage of trading using opposite Live Ventures and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Live Ventures position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.| Live Ventures vs. Arhaus Inc | Live Ventures vs. Floor Decor Holdings | Live Ventures vs. Haverty Furniture Companies | Live Ventures vs. Kingfisher plc |
| Centessa Pharmaceuticals vs. Beam Therapeutics | Centessa Pharmaceuticals vs. Editas Medicine | Centessa Pharmaceuticals vs. Caribou Biosciences | Centessa Pharmaceuticals vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |